21 hours ago
OBIO
AnalystsMadison El-SaadiMadison El-Saadi's Stock Forecasts
AnalystsMadison El-Saadi
Analyst Ranking
Top 26%
#1439 out of 5511 analysts
Average Return
+8.9%
Win Rate
46%12 out of 26
Risk vs Reward
Poor
Good
Madison El-Saadi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +198.62% | $10.18 | $30.40 | 2025-06-26 - 2026-06-25 | Strong Buy |
Eton Pharmaceuticals IncETON | +146.10% | $22.32 | $54.93 | 2026-03-20 - 2026-09-15 | Strong Buy |
Axsome Therapeutics IncAXSM | +72.11% | $118.57 | $204.07 | 2025-10-01 - 2026-09-15 | Strong Buy |
Eton Pharmaceuticals IncETON | +59.85% | $18.93 | $30.26 | 2025-05-16 - 2026-05-15 | Strong Buy |
Compass Pathways PLCCMPS | +44.15% | $9.58 | $13.81 | 2026-04-24 - 2026-09-15 | Strong Buy |
Madison El-Saadi Analyst Color
Get additional color on Madison El-Saadi's coverage of popular stocks
a month ago
ETON
Madison El-Saadi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Orchestra Biomed Holdings IncOBIO | 1 | Strong Buy | $11.00 | +82.12% | Maintains | 21 hours ago |
Capricor Therapeutics IncCAPR | 4 | Strong Buy | $21.00 | +145.33% | Upgrades | 2 days ago |
Neuronetics IncSTIM | 1 | Strong Buy | $5.00 | +78.57% | Initiates Coverage On | 5 days ago |
Eton Pharmaceuticals IncETON | 5 | Strong Buy | $70.00 | +27.43% | Reiterates | a month ago |
Fennec Pharmaceuticals IncFENC | 1 | Strong Buy | $18.00 | +69.17% | Reiterates | a month ago |
Vanda Pharmaceuticals IncVNDA | 3 | Strong Buy | $12.00 | +140.48% | Reiterates | a month ago |
Compass Pathways PLCCMPS | 2 | Strong Buy | $22.00 | +59.30% | Maintains | a month ago |
Wave Life Sciences IncWVE | 5 | Strong Buy | $22.00 | +393.27% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $123.00 | +74.05% | Maintains | 2 months ago |
Spruce Biosciences IncSPRB | 1 | Strong Buy | $160.00 | +190.04% | Initiates Coverage On | 2 months ago |
Axsome Therapeutics IncAXSM | 1 | Strong Buy | $179.00 | -12.29% | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.